These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33859156)

  • 1. An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage.
    Bi X; Zhang Q; Zhuang F; Lu W; Wang Y; Ding F
    Med Sci Monit; 2021 Apr; 27():e930513. PubMed ID: 33859156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.
    Kreuzer M; Ahlenstiel T; Kanzelmeyer N; Ehrich JH; Pape L
    Pediatr Nephrol; 2010 Jul; 25(7):1305-10. PubMed ID: 20221775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of regional citrate anticoagulation with medium cut-off membrane: pilot report.
    Vrečko MM; Pajek J; Buturović-Ponikvar J
    BMC Nephrol; 2022 Oct; 23(1):346. PubMed ID: 36303108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
    Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
    Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated regional citrate anticoagulation: technological barriers and possible solutions.
    Szamosfalvi B; Frinak S; Yee J
    Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in Inflammation and Calcium Balance of Citrate versus Acetate as Dialysate Buffer in Maintenance Hemodialysis: A Unicentric, Cross-Over, Prospective Study.
    Broseta JJ; López-Romero LC; Cerveró A; Devesa-Such R; Soldevila A; Bea-Granell S; Sánchez-Pérez P; Hernández-Jaras J
    Blood Purif; 2021; 50(6):914-920. PubMed ID: 33535212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis: a prospective multicenter randomized controlled trial.
    Tang X; Chen D; Zhang L; Fu P; Chen Y; Xiao Z; Xiao X; Peng W; Cheng L; Zhang Y; Li H; Li K; Gou B; Wu X; Yu Q; Jian L; Zhu Z; Wen Y; Liu C; Xue H; Zhang H; He X; Yan B; Zhong L; Huang B; Mao M
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):931-942. PubMed ID: 36379612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs.
    Francey T; Schweighauser A
    J Vet Intern Med; 2018 Jan; 32(1):147-156. PubMed ID: 29171099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
    Schneider M; Liefeldt L; Slowinski T; Peters H; Neumayer HH; Morgera S
    Int J Artif Organs; 2008 Jan; 31(1):43-8. PubMed ID: 18286453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.
    Thijssen S; Kossmann RJ; Kruse A; Kotanko P
    Blood Purif; 2013; 35(1-3):133-8. PubMed ID: 23343558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified protocol for individualized regional citrate anticoagulation for hemodialysis: A single-center, randomized clinical study.
    Luo L; Fan M; Chen Q; Cheng J
    Medicine (Baltimore); 2021 Feb; 100(8):e24639. PubMed ID: 33663073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.
    Lin T; Song L; Huang R; Huang Y; Tang S; Lin Q; Zhang Y; Wu X; Liang H; Wu Y; Chen Y; Liang H; Ma J; Feng Z; Li Z; Xu L; Fu X; Ye Z; Liu S; Liang X
    BMC Nephrol; 2019 Dec; 20(1):472. PubMed ID: 31856749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Focus on citrate accumulation.
    Persic V; Vajdic Trampuz B; Medved B; Pavcnik M; Ponikvar R; Gubensek J
    Artif Organs; 2020 May; 44(5):497-503. PubMed ID: 31851381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
    Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.